Inactive Instrument

PHARMAGEST INTER. Stock Euronext Paris

Equities

FR0000077687

IT Services & Consulting

End-of-day quote Euronext Paris
- EUR - Intraday chart for PHARMAGEST INTER.
Sales 2023 220M 235M Sales 2024 * 231M 248M Capitalization 893M 955M
Net income 2023 47M 50.27M Net income 2024 * 49M 52.41M EV / Sales 2023 4.18 x
Net cash position 2023 * 35.92M 38.43M Net cash position 2024 * 64.17M 68.64M EV / Sales 2024 * 3.58 x
P/E ratio 2023
19.5 x
P/E ratio 2024 *
17.8 x
Employees -
Yield 2023 *
2.05%
Yield 2024 *
2.24%
Free-Float 32.43%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 55 90-12-31
Founder 65 96-01-24
Director of Finance/CFO - 22-12-31
Members of the board TitleAgeSince
Founder 65 96-01-24
Director/Board Member 46 17-06-26
Director/Board Member 59 99-12-31
More insiders
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows: - pharmacy software publishing and integration (73%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.; - publishing of IT solutions for health and medical/social establishments (15.2%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.); - development of solutions and infrastructures for e-Health (11.8%): digital communication, telemedicine and telehealth solutions. The group also offers financing solutions for leased goods (Nanceo). Net sales are distributed geographically as follows: France (90.9%), Italy (4.9%), Belgium and Luxembourg (2.7%), Ireland and the United Kingdom (0.8%) and Germany (0.7%).
More about the company